We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
D4t4 Solutions Plc | D4T4 | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
176.00 | 176.00 |
Top Posts |
---|
Posted at 11/7/2023 06:59 by mancman1 Presentation this afternoon: |
Posted at 23/7/2022 11:51 by gerihatrick Good interview with Bill Bruno on Master Investor. Key points for me...any company investing in their software has a ROI in 6 months...amazing stat! They have a balance between profit and growth, and while they have no imminent M and A, they keep this aspect under constant review. This year they have made a 4% dividend plus a "special" dividend in light of profit. They have 2 updates of software every year and have to make appropriate changes to move with compliance across the 27 countries in which they operate, plus any changes that may be made by individual US states. I hold.Thanks vprt for Richard Beddard review. VectorVest rates it as a hold on their very precise criteria. |
Posted at 02/12/2021 13:44 by ali47fish truncated note from champion investor sounds very positivePREMIUM- only part of post but sounds positive Data specialist is thriving in a booming market (Updated) 02/12/2021 AIM TECHNOLOGY Comments (1) Email Print Share The growth potential of this provider of sophisticated d The data and analytics market encompasses 'big data', artificial intelligence, machine learning and the business intelligence market. It is estimated to be valued at U$189 billion by the global independent analyst International Data Corporation (IDC), with projected growth of 13.2% annually until 2022, by which time it will have grown to U$274 billion. D4t4 Solutions (LON:D4T4) has developed pioneering technology which enhances the accuracy and completeness of data collection and analysis. D4T4 is focused on the finance and consumer sectors, with specific areas of… |
Posted at 02/12/2021 08:34 by apad Perfectly sensible analysis, Dr. Biotech.I take it that investors are impatient with the flat ARR number and the loss of an airline customer. The company commenting on second half weighting and contracts in the offing is not enough. Maybe their customers have enough on their plates dealing with the panicdemic than to be attending to software contract changes. Certainly, some companies are talking about the difficulties of selling because of covid restrictions. Revenue is up about 50% and there is a suite of new programs. So, on balance, I see the current share price fall as the start of a BTFD opportunity. However, I am surprised at the extent of the drop. apad |
Posted at 02/11/2021 16:20 by redartbmud Acquisitions and Mergers board (PTM) rules, an investor who acquires, exceeds or falls below 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10% and each 1% threshold thereafter up to 100% of a UK Company, must, under the Companies Act 1985 Section 198, disclose their interests to the London Stock Exchange and the company, within two days. |
Posted at 16/6/2021 12:55 by apad I should warn that I am a conviction, high risk, investor.BOO FEVR BVXP TSTL are 70% of my portfolio. FWIW apad |
Posted at 21/4/2021 21:06 by norbert colon https://investor.ter |
Posted at 04/12/2020 10:44 by energeticbacker Investor's Champion comments that while it has taken a long time coming, D4T4 appears to have an extremely exciting future in a rapidly growing sector.Although investor focus should remain on the top line growth and recurring revenue, there is already a lot to like about a business generating plenty of cash and an operating margin and return on equity of 20%+. |
Posted at 25/11/2020 11:50 by energeticbacker Investor's Champion comments that while it has taken a long time coming, D4T4 appears to have an extremely exciting future in a rapidly growing sector.Although investor focus should remain on the top line growth and recurring revenue, there is already a lot to like about a business generating plenty of cash and an operating margin and return on equity of 20%+. Updated commentary on their website. |
Posted at 08/8/2020 13:14 by norbert colon It depends what metrics you use to value it. On a traditional earnings basis it now looks expensive but the SaaS transition will remove the historical lumpiness and increase the quality of earnings so they will merit a higher valuation.If you value the business on a multiple of sales its not expensive especially when compared to a comparative US listed business.With Cannacord now onboard as joint broker they should attract more interest from US investors who will hopefully see the valuation as attractive. The fact that the valuation has held up since the new forecasts were released intimates that investors are seeing long term value here. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions